Dihexa Canada is available and currently in stock through Vancouver Island Peptides — synthesized domestically at our Vancouver, BC lab partner. Research-grade oligopeptide, produced in British Columbia, ships Canada-wide in discreet packaging.
Available in 4mg lyophilized powder vials.
Dihexa (developmental code PNB-0408) is an oligopeptide derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at the c-Met receptor. The compound has been found to potently improve cognitive function in animal models of cognitive impairment. Notably, in assays of neurotrophic activity, Dihexa demonstrated potency seven orders of magnitude greater than BDNF (Brain-Derived Neurotrophic Factor) — making it one of the most potent neurotrophic compounds ever studied. As a domestic peptide in Canada, our Dihexa is produced in British Columbia under strict quality controls.
| Product Name | Dihexa (PNB-0408) |
| Format | Lyophilized Powder |
| Available Size | 4mg |
| Purity | >99% (HPLC verified) |
| Storage | −20°C, away from light |
| Origin | Domestic — Vancouver, BC, Canada |
| Availability | In Stock |
| Shipping | Canada-wide, discreet packaging |
As a highly potent neurotrophic compound, Dihexa purity is critical for research accuracy. Our Dihexa Canada is produced at our Vancouver, BC lab partner and verified to greater than 99% purity by HPLC. No overseas sourcing, no import uncertainty — domestic quality control from synthesis to shipment.
Store lyophilized Dihexa at −20°C away from light. Reconstitute using bacteriostatic water. Introduce liquid slowly along the vial wall and allow to dissolve without agitation. Handle under sterile laboratory conditions throughout the research period.
View Dihexa on the Store